5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 3.09▲ | 3.11▼ | 3.11▼ | 3.12▼ | 3.08▲ |
MA10 | 3.09▲ | 3.11▼ | 3.11▼ | 3.12▼ | 3.04▲ |
MA20 | 3.12▼ | 3.12▼ | 3.11▼ | 3.08▲ | 3.01▲ |
MA50 | 3.12▼ | 3.14▼ | 3.14▼ | 3.01▲ | 2.93▲ |
MA100 | 3.15▼ | 3.03▲ | 2.98▲ | 2.97▲ | 3.02▲ |
MA200 | 2.89▲ | 2.84▲ | 2.91▲ | 2.91▲ | 12.18▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.003▼ | -0.003▼ | 0.000▲ | 0.025▲ |
RSI | 49.158▼ | 48.712▼ | 49.081▼ | 51.307▲ | 51.729▲ |
STOCH | 60.049 | 61.218 | 61.218 | 70.535 | 52.222 |
WILL %R | -46.154 | -46.154 | -46.154 | -29.898 | -47.141 |
CCI | -11.523 | -40.969 | -33.131 | 28.191 | 52.320 |
Sunday, April 20, 2025 05:00 PM
89.9% of NewAmsterdam Pharma shares are owned by institutional investors. Comparatively, 75.6% of Cyclerion Therapeutics shares are owned by institutional investors. 19.5% of NewAmsterdam Pharma ...
|
Saturday, March 15, 2025 05:00 PM
Guggenheim started coverage on shares of Cybin (NYSE:CYBN – Free Report) in a report published on Thursday, MarketBeat reports. The firm issued a buy rating and a $35.00 price target on the stock.
|
Tuesday, December 17, 2024 05:11 AM
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Company’s next stage of growth.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 2.94 | 3.1942 | 2.93 | 3.1136 | 9,411 |
12/06/25 | 3.13 | 3.1842 | 2.92 | 3.1004 | 16,221 |
11/06/25 | 3.09 | 3.197 | 2.94 | 3.01 | 13,720 |
10/06/25 | 3.215 | 3.215 | 3.215 | 3.215 | 4,380 |
09/06/25 | 3.19 | 3.249 | 3.0802 | 3.1441 | 10,274 |
06/06/25 | 3.19 | 3.1938 | 3.0404 | 3.18 | 15,153 |
05/06/25 | 3.01 | 3.2552 | 3.01 | 3.17 | 8,867 |
04/06/25 | 3.13 | 3.2499 | 3.01 | 3.13 | 20,352 |
03/06/25 | 2.84 | 3.29 | 2.80 | 3.205 | 48,250 |
02/06/25 | 2.80 | 3.02 | 2.7664 | 2.96 | 12,940 |
|
|
||||
|
|
||||
|
|